Department of neurology, Nordsjællands Hospital
Hillerød, 3400, Denmark
NCT Number: NCT03648957
Interventions to improve health behaviour in patients with resent acute stroke are not well established. This study will evaluate the feasibility and effect of an early initiated counselling intervention targeting smoking, physical activity, and adherence to preventive medication, with regular follow-up sessions, in patients with acute minor stroke or transient ischemic attack who are discharged home.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Hillerød, 3400, Denmark
Stroke is a significant cause of morbidity, mortality, and loss of independence worldwide. In Denmark 12,000 people have a stroke per year. About one fourth of patients admitted with a stroke have had previous strokes or transient ischemic attack (TIA). The risk of recurrent stroke is highest in the first weeks and decreasing with time.
In the last decades there has been an increased focus on the importance of health behaviour in the public and among patients in relations to prevention of vascular diseases. There is solid scientific evidence of the harmful effects of lifestyle factors, such as smoking, physical inactivity, and alcohol overuse.
Hypertension is one of the leading risk factors for vascular diseases, including stroke and TIA. Lowering of the blood pressure is therefore an essential part of stroke treatment. Smoking cessation, physical activity, and adherence to antihypertensive and antithrombotic medication is highly recommended in patients with minor stroke and TIA.
There is still a lack of knowledge about how to support patients in making suitable choices to prevent recurrence and progression of their disease. Previous research has shown varying results and it is therefore difficult to point out any specific intervention or element of interventions which would be feasible to implement in clinical practice.
The hypothesis of the study is that early client-centred patient counselling with repeated follow-up sessions after discharge can reduce the blood pressure through smoking cessation, physical activity, and improved adherence to preventive medication in patients with minor stroke and transient ischemic attacks compared to simple encouragement to lifestyle change.
The overall purpose of our research is to develop effective and clinically feasible interventions to prevent recurrent strokes in patients with minor stroke and transient ischemic attacks, and identify unmet needs in the newly discharged patients and their relatives.
The PhD study will comprise of 1) a randomized feasibility trial (n=40) aiming to test a combined behavioural and clinical intervention with follow-up sessions post-discharge with 3-4 weeks intervals in 12 weeks on reducing blood pressure in patients with minor stroke and transient ischemic attack 2) a qualitative study to explore the patients attitudes and experiences towards medicine adherence, lifestyle changes, social support, and self-efficacy.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
First behavioral counselling session will be conducted before discharge and follow-up session will be offered with 3-4 weeks intervals either by telephone or in the outpatient clinic.
Usual stroke care discharge session; including written and verbal encouragement to a healthy lifestyle.
Participants are encouraged to wear a activity tracker to monitor their physical activity
Time frame: At baseline (0 weeks) and end of intervention (12 weeks)
Change in resting systolic blood pressure from baseline to three months follow-up
Time frame: 12 weeks
Proportion of eligible patients included in the study
Time frame: From baseline (0 weeks) until the end of intervention (12 weeks)
Proportion of included participants adhering to and completing the study protocol
Time frame: At baseline (0 weeks) and end of intervention (12 weeks)
Number of participants currently smoking tobacco (self-reported)
Time frame: From baseline (0 weeks) until the end of intervention (12 weeks)
Time used per week on physical activity (self-reported)
Time frame: Previous seven days until the end of the intervention (12 weeks)
Proportion of taken/missed doses of preventive medication within the last seven days; antithrombotic, anticoagulants, antihypertensiva & lipid-lowering drugs (self-reported)
Time frame: At baseline (0 weeks) and end of intervention (12 weeks)
Ratio between waist- and hip circumference (cm)
Time frame: At baseline (0 weeks) and end of intervention (12 weeks)
Body weight relative to height
Time frame: At the end of the intervention (12 weeks)
10 item questionnaire with 5-level likert scales assessing health related fatigue and the impact of fatigue on everyday activity
Time frame: At baseline (0 weeks) and end of intervention (12 weeks)
Two item questionnaire
Time frame: 52 weeks
Incidence of new stroke, TIA, ischemic heart disease, or all-cause death (combined)
Nordsjaellands Hospital
Other
Lifestyle Counselling as Secondary Prevention in Patients With Minor Stroke and Transient Ischemic Attack: A Randomized Controlled Feasibility Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04000971
Behavior, Brain Diseases
Birmingham, Alabama, United States
View Trial DetailsNCT04038697
Brain Diseases, Cardiovascular Diseases
Milwaukee, Wisconsin, United States
View Trial DetailsNCT05936008
Behavior, Brain Diseases
Kansas City, Kansas, United States
View Trial DetailsNCT05029284
Brain Diseases, Cardiovascular Diseases
Minneapolis, Minnesota, United States
View Trial Details